Viewing Study NCT01457768


Ignite Creation Date: 2025-12-24 @ 5:31 PM
Ignite Modification Date: 2026-01-01 @ 8:58 PM
Study NCT ID: NCT01457768
Status: COMPLETED
Last Update Posted: 2018-05-04
First Post: 2011-10-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Sponsor: Gilead Sciences
Organization:

Study Overview

Official Title: A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects With Chronic Hepatitis C Infection
Status: COMPLETED
Status Verified Date: 2018-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2011-000946-39 EUDRACT_NUMBER None View